Stay Updated
Press Releases
WASHINGTON, D.C. — AstraZeneca has petitioned the U.S. Supreme Court in a desperate attempt to overturn its 2024 loss in federal court and stop Medicare from negotiating lower drug prices for U.S. patients. The move marks an escalation of pharma’s nationwide legal campaign to preserve the industry’s monopoly pricing power, and would strip President Trump’s […]
Press Releases
Federal Court Rejects Novartis’s Case Against Medicare Negotiation
The unanimous decision marks the 14th ruling against Big Pharma and in favor of patients. WASHINGTON, D.C. — Today, the U.S. Court of Appeals For The Third Circuit unanimously rejected Novartis’ challenge to the Medicare Drug Price Negotiation Program, exactly one week after the same court delivered a similar defeat to Bristol Myers Squibb […]
Press Releases
Another Patient Victory: Federal Court Rejects BMS and Janssen’s Case Against Medicare Negotiation
WASHINGTON, D.C. — This morning, the U.S. Court of Appeals For The Third Circuit rejected Bristol Myers Squibb (BMS) and Janssen’s challenge to the Medicare Drug Price Negotiation Program, standing with patients and affirming the earlier district court decision that the program is constitutional. Following pharma’s three legal defeats in August, this latest decision marks the 13th ruling in favor of […]
Press Releases
ICYMI: Courts Deliver Three Major Legal Wins for Medicare Drug Price Negotiation in Just Two Days
WASHINGTON, D.C. — Over the span of just 48 hours, three federal courts delivered resounding defeats to Big Pharma’s legal campaign to overturn the Medicare Drug Price Negotiation Program — marking the 10th, 11th, and 12th rulings in favor of patients and the law that’s set to deliver lower drug prices to 9 million people on […]
Press Releases
The U.S. Court of Appeals for the Second Circuit stood with a lower court’s 2024 decision ruling against Boehringer Ingelheim WASHINGTON, D.C. — In yet another decisive win for patients, the U.S. Court of Appeals for the Second Circuit rejected Boehringer Ingelheim’s attempt to block Medicare’s authority to negotiate lower drug prices. This marks the second win in less than 24 […]
Press Releases
PHARMA DEFEAT: Federal Court Rejects U.S. Chamber of Commerce’s Case Against Medicare Negotiation
The U.S. Court of Appeals for the Sixth Circuit stood with the lower court’s 2024 decision to dismiss the U.S. Chamber of Commerce’s Case WASHINGTON, D.C. — In another blow to pharma’s multi-million dollar legal campaign against the Medicare Negotiation Program, today the Sixth Circuit U.S. Court of Appeals blocked a legal challenge to […]
Press Releases
Analysis found that drug research spending “increased to record levels” in the six quarters following the IRA’s passage in 2022 WASHINGTON, D.C. — New analysis from Bentley University demolishes Big Pharma’s core talking point that Medicare negotiation would kill drug research and development (R&D). The study found that after flatlining from 2020 to 2022, drug […]
Press Releases
ICYMI: P4AD Releases Report Exposing Six Pharma-Funded Front Groups Keeping Drug Prices High
WASHINGTON, D.C. — Last week, Patients For Affordable Drugs released a new report, The Rampant Reach of Pharma’s Hidden Hand, uncovering the pharmaceutical industry’s efforts to fund, influence — and in some cases, fully operate — front groups that claim to represent the interests of patients while working to protect drug company profits. Each of […]